November 12, 2024
BERKELEY, US and MAINZ, Germany – Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced a collaborative agreement with Thermo Fisher Scientific Inc. (NYSE: TMO), through its subsidiary Life Technologies Corporation (“Thermo Fisher”), a world leader in supplying life sciences solutions and services. [...]
Introducing the JEM-Z200MF: A Revolutionary Magnetic Field-Free Atomic Resolution Imaging System
November 12, 2024
JEOL is proud to announce the JEM-Z200MF, a state-of-the-art scanning/transmission electron microscope (S/TEM) designed for atomic resolution imaging in a magnetic field-free environment. The MARS (Magnetic field-free Atomic Resolution imaging System) enables high resolution observation without applying strong magnetic field to specimen. This observation method is expected to become a groundbreaking tool that will significantly advance [...]
November 11, 2024
WALTHAM, Mass. -- Everest Biolabs, the life sciences company dedicated to equipping scientists with essential tools for their extracellular vesicle (EV) and exosome research, came out of stealth today with the release of innovative isolation and analytical tools for EV and exosome biomarker research at the 2024 American Association of Extracellular Vesicles (AAEV2024) annual meeting in Houston, Texas. Today, Everest Biolabs [...]
GenScript Biotech Sets Up New Operations and Logistics Hub in Sydney, Australia
November 11, 2024
GenScript Biotech Corporation (“GenScript”), a global leader in life sciences services and products, has announced the establishment of new operations site and logistics center in Sydney, Australia. This strategic expansion represents a significant milestone in GenScript’s continued commitment to supporting the rapid growth of the biotechnology sector in Australia. It also underscores the company's determination [...]
Oxford Nanopore announces senior leadership changes
November 11, 2024
Oxford Nanopore Technologies today announced that Rosemary Sinclair Dokos has been appointed as Chief Product and Marketing Officer and Dr Lakmal Jayasinghe has been appointed as Chief Scientific Officer, effective immediately. Rosemary and Lakmal succeed Clive Brown, Chief Officer of Technology, Innovation, and Products, who has stepped down to pursue new projects. Clive will be [...]
November 8, 2024
eLabNext and BU’s DAMP Lab partner to launch 'DAMP Lab Canvas,' a platform to streamline molecular biology service ordering, announced at the 2024 BioManufacturing Automation Workshop. The Design, Automation, Manufacturing, and Processes (DAMP) Lab and eLabNext announced a formal partnership today to coincide with the kick-off of the International Workshop for BioManufacturing Automation 2024 at Boston University (BU). The [...]
November 8, 2024
New England Biolabs Lyophilization Sciences® further strengthens its ability to deliver a best-in-class solution for customers in need of lyophilized products IPSWICH, Mass. -- New England Biolabs (NEB®), a leading supplier of life science reagents, announced the opening of its first manufacturing facility outside of the United States. New England Biolabs Lyophilization Sciences (NEB Lyo Sciences®) joins NEB's [...]
Park Systems India Announces New Strategic Partnership with Labindia Instruments
November 8, 2024
SUWON, South Korea -- Park Systems (CEO Dr. Sang-il Park), a leading provider of nanometrology solutions with Atomic Force Microscopy (AFM) and Imaging Spectroscopic Ellipsometry (ISE), is proud to announce a new partnership with Labindia Instruments Pvt. Ltd. for business expansion in India. (Left to Right) Representatives from Labindia Instruments Pvt. Ltd. and Park Systems gather for the [...]
November 8, 2024
New Technology Expands Antibody Compatibility and Doubles Throughput while maintaining Tissue Integrity and Lack of Cross-Reactivity BILLERICA, Mass. -- Bruker Corporation (Nasdaq: BRKR) today announced a major technological breakthrough in the CellScape™ Precise Spatial Proteomics platform for highly multiplexed immunofluorescence (IF). Launched in 2022, the CellScape platform has advanced the field of spatial proteomics with differentiated quantitative performance [...]
November 8, 2024
SHANGHAI -- Illumina Hong Kong LIMITED (Illumina), a global leader in DNA sequencing and array-based technologies, and PHASE Scientific International Limited (PHASE), a Hong Kong-based biotech company with operations in the U.S. and the Greater Bay Area (GBA), signed a three-year Memorandum of Understanding (MoU) on 7 November at the 7th China International Import Expo. The two [...]

